These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
40 related articles for article (PubMed ID: 10731111)
21. Aromatase and its inhibitors. Brodie A; Lu Q; Long B J Steroid Biochem Mol Biol; 1999; 69(1-6):205-10. PubMed ID: 10418994 [TBL] [Abstract][Full Text] [Related]
23. Aromatase inhibitors and their application in breast cancer treatment*. Brodie AM; Njar VC Steroids; 2000 Apr; 65(4):171-9. PubMed ID: 10713305 [TBL] [Abstract][Full Text] [Related]
24. Aromatase inhibitors and their use in the sequential setting. Coombes RC; Harper-Wynne C; Dowsett M Endocr Relat Cancer; 1999 Jun; 6(2):259-63. PubMed ID: 10731118 [TBL] [Abstract][Full Text] [Related]
25. Drug and hormone interactions of aromatase inhibitors. Dowsett M Endocr Relat Cancer; 1999 Jun; 6(2):181-5. PubMed ID: 10731107 [TBL] [Abstract][Full Text] [Related]
26. Steroid control and sexual differentiation of brain aromatase. Balthazart J J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):323-39. PubMed ID: 9365208 [TBL] [Abstract][Full Text] [Related]
27. Pre-clinical and clinical review of vorozole, a new third generation aromatase inhibitor. Goss PE Breast Cancer Res Treat; 1998; 49 Suppl 1():S59-65; discussion S73-7. PubMed ID: 9797019 [TBL] [Abstract][Full Text] [Related]
28. Aromatase inhibitors: new endocrine treatment of breast cancer. Brueggemeier RW Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379 [TBL] [Abstract][Full Text] [Related]
29. Aromatase and its inhibitors--an overview. Brodie A J Steroid Biochem Mol Biol; 1991; 40(1-3):255-61. PubMed ID: 1958529 [TBL] [Abstract][Full Text] [Related]
30. Are differences in the available aromatase inhibitors and inactivators significant? Johnson PE; Buzdar A Clin Cancer Res; 2001 Dec; 7(12 Suppl):4360s-4368s; discussion 4411s-4412s. PubMed ID: 11916226 [TBL] [Abstract][Full Text] [Related]
34. Aromatase inhibition for breast cancer treatment. Lønning PE Acta Oncol; 1996; 35 Suppl 5():38-43. PubMed ID: 9142963 [TBL] [Abstract][Full Text] [Related]
35. Aromatase inhibitors and their use in the adjuvant setting. Coombes RC Recent Results Cancer Res; 1998; 152():277-84. PubMed ID: 9928565 [TBL] [Abstract][Full Text] [Related]
37. Effects of testosterone and its metabolites on aromatase-immunoreactive cells in the quail brain: relationship with the activation of male reproductive behavior. Balthazart J; Foidart A; Absil P; Harada N J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):185-200. PubMed ID: 8603040 [TBL] [Abstract][Full Text] [Related]